She is not disruptive. She is quiet, she is anxious, she loses things, she cries about homework at nine at night, and three separate adults have described her as bright but not applying herself. Nobody has mentioned attention, because the picture in everyone's head is a boy out of his seat.

The short answer: the evidence for a diagnostic gap is better than the usual anecdotes suggest, and the sharpest finding is this — in a population sample of 19,804 children linked to national diagnostic registers, girls in the community had lower ADHD symptom scores than boys, but "similar severity was seen in clinically diagnosed males and females." Girls who reach a diagnosis are as impaired as boys who do, which means the threshold they had to cross was higher. In the same study, hyperactive and conduct behaviours predicted diagnosis and medication more strongly in girls than boys, and the authors concluded that "Females with ADHD may be more easily missed in the ADHD diagnostic process and less likely to be prescribed medication unless they have prominent externalising problems." The relative-age effect is more than twice as strong in girls. And 14.5 percent of US boys have a current diagnosis against 8.8 percent of girls.¹ ² ³

The three findings that matter

1. The diagnosed gap. In the 2024 national survey, "A higher percentage of boys than girls had a current ADHD diagnosis (14.5% vs. 8.8%)."³ A ratio of about 1.6 to 1 in diagnosis.

2. Diagnosed girls are as impaired as diagnosed boys. The Swedish twin study assessed ADHD symptoms dimensionally in 19,804 nine-year-olds and then linked them to national records of who was actually diagnosed and medicated. At the population level boys scored higher on every symptom domain — "but similar severity was seen in clinically diagnosed males and females."¹

That sentence does the work. If the diagnostic process were applying the same threshold to both, you would expect diagnosed girls to look less severe on average, because fewer of them cross a fixed line. They do not. They look the same, which implies the line sits higher for them.

3. What gets a girl diagnosed is behaviour that looks like a boy's. In the same study, hyperactivity/impulsivity and conduct problems "were stronger predictors of clinical diagnosis (hyperactivity/impulsivity: OR 1.08, 95% CI 1.01, 1.15; conduct: OR 1.43, 95% CI 1.09, 1.87), and prescription of pharmacological treatment (hyperactivity/impulsivity: OR 1.24, 95% CI 1.02, 1.50; conduct: OR 2.20, 95% CI 1.05, 4.63)" in females than in males. The conclusion: "Females with ADHD may be more easily missed in the ADHD diagnostic process and less likely to be prescribed medication unless they have prominent externalising problems."¹

A girl who is disruptive gets seen. A girl who is not, does not.

Why the mechanism is about referral, not about girls having less ADHD

The community-versus-clinic comparison is the giveaway. A meta-analysis of 86 child studies covering 163,688 children found that "the predominantly inattentive type is the most common subtype in the population, but individuals with the combined type are more likely to be referred for clinical services."²

Put those two facts together. Girls are disproportionately in the inattentive presentation. The combined presentation — the visibly disruptive one — is what drives referral. So the filter between "has ADHD" and "gets assessed for ADHD" is a filter that selects against the way ADHD more often looks in girls.

The same meta-analysis found pooled prevalence estimates in the community are similar whether ADHD is defined by parent ratings, teacher ratings or a best-estimate diagnostic procedure — 5.9 to 7.1 percent — and called for research "to determine the etiology of the higher prevalence of ADHD in males than females."²

And a finding almost nobody connects to this

The relative-age effect — the fact that the youngest children in a school year are diagnosed more often — is more than twice as strong in girls.

In a cohort of 937,943 children in British Columbia, boys born in December were 30 percent more likely to be diagnosed than boys born in January (relative risk 1.30, 95% CI 1.23–1.37). Girls born in December were 70 percent more likely than girls born in January (1.70, 1.53–1.88). For medication, 41 percent in boys and 77 percent in girls.⁴

One reading: because the threshold for noticing a girl is higher, a girl needs an extra push to cross it — and being eleven months younger than her classmates supplies exactly that push. The corollary is uncomfortable: many girls who are older in their year, with the same difficulties, are never noticed at all.

What parents of girls are told, and what to say instead

"She's doing fine academically." Impairment does not have to be academic. The criteria require impairment in more than one major setting — "social, academic, or occupational" — and a girl who is holding her grades together by working until midnight and crying afterwards is impaired.⁵

"She's just anxious." Very possibly both. About four in ten children with ADHD also have anxiety, and 77.9 percent of children with ADHD have at least one co-occurring condition.⁶ Cognitive testing does not cleanly separate them: one study of children with ADHD, anxiety and both concluded "We did not find strong evidence for disorder-specific deficits in attention or cognitive control."⁷ The guideline's answer is to screen for both rather than to choose.⁵

"She's not hyperactive." Hyperactivity is not required. The inattentive presentation is the most common one in the community.²

"She's bright, so it can't be that." Treatment response does not vary with intelligence: in 502 children in a double-blind placebo-controlled crossover, "No significant differences were found with regards to treatment response" across the normal-to-gifted range.⁸

"You're an anxious mother." There is direct evidence that parents rate diagnosed girls' hyperactive and impulsive symptoms lower than a structured interview does, and diagnosed boys' higher — so parent under-reporting for girls is itself part of the mechanism.⁹ Which is an argument for bringing observations from more than one setting, in writing.

What to bring to the appointment

The evaluation requires "documentation of symptoms and impairment in more than 1 major setting… with information obtained primarily from reports from parents or guardians, teachers, other school personnel."⁵ For a girl whose difficulty is internal, that documentation has to be constructed deliberately, because it will not arrive on its own from a teacher who has no complaints.

  • The homework time. Not "she struggles" — how many minutes, how many restarts, how often it ends in tears. Track it for two weeks.
  • The effort cost. What she is doing to keep up: rereading, late nights, giving up activities, checking work repeatedly.
  • The social side. Interrupting, missing cues, friendships that flare and end, exhaustion after school from holding it together all day.
  • The internal symptoms. Losing track mid-sentence, rereading a page four times, forgetting what she came upstairs for, mental restlessness rather than physical.
  • A teacher's account, in writing, to specific questions. "Does she start work promptly? Does she finish? Does she need instructions repeated? Is she noticeably slower to get going than her classmates?" A general "she's lovely" tells an assessor nothing.
  • Her age within the school year, and the request that it be taken into account.⁴
  • Family history, including undiagnosed relatives who "were just like that."

The printable evaluation prep → · What else looks like ADHD in children →

If she is already an adult

The same filter has been operating for decades, which is why so many women are diagnosed after their own child is. Why ADHD gets missed in women → · Diagnosed late: what to do with that → · The adult ADHD map →

Q&A

Q: Is ADHD underdiagnosed in girls? A: The evidence points that way. Diagnosed girls are as impaired as diagnosed boys despite lower symptom scores in the community, and hyperactive and conduct behaviours predict diagnosis and medication more strongly in girls than in boys.¹ The authors' conclusion is that females "may be more easily missed in the ADHD diagnostic process and less likely to be prescribed medication unless they have prominent externalising problems."

Q: Do girls have a different kind of ADHD? A: The presentations are the same categories; the distribution differs, with girls more often in the inattentive presentation — which is also the presentation least likely to be referred.²

Q: My daughter's teacher says there's no problem. A: Common, and worth converting into specific questions rather than accepting as a global judgment. A child who is quiet and compliant creates no problem for a classroom while having a considerable one herself.

Q: Could it be anxiety instead? A: It could be either, and it is frequently both. The guideline requires screening for anxiety as part of an ADHD evaluation rather than treating them as alternatives.⁵ ⁶

Q: She was diagnosed and I'm not sure the medication is right for a girl. A: The medication evidence base includes both, and the network meta-analysis does not report sex-specific efficacy differences for children.¹⁰ What is worth watching is that she was as impaired as her diagnosed male peers before treatment — which is an argument for treating the impairment seriously rather than tentatively. The medication decision →

Q: Is it too late if she's fifteen? A: No. Adolescents are covered by the same guideline, with the added requirement of her own assent to any medication.⁵ And a name for what has been happening is, for a lot of girls this age, the part that changes the most.

Ready to find someone who will actually look? Filter by approach, schedule and payment route → · ADHD in children: the parent map → · Why ADHD gets missed in women →

In crisis? Call or text 988 — free, 24/7.

Sources

  1. Mowlem FD, Rosenqvist MA, Martin J, Lichtenstein P, Asherson P, Larsson H, "Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment," European Child and Adolescent Psychiatry 28(4), 2019, 481–489 — 19,804 twins assessed at age 9 and linked to national registers; "At the population level, males had higher scores for all symptom domains… but similar severity was seen in clinically diagnosed males and females"; the odds ratios for hyperactivity/impulsivity and conduct predicting diagnosis and treatment in females; "Females with ADHD may be more easily missed in the ADHD diagnostic process and less likely to be prescribed medication unless they have prominent externalising problems" — pmc.ncbi.nlm.nih.gov.
  2. Willcutt EG, "The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review," Neurotherapeutics 9(3), 2012, 490–499 — 86 child studies, 163,688 children; "the predominantly inattentive type is the most common subtype in the population, but individuals with the combined type are more likely to be referred for clinical services"; community prevalence 5.9–7.1% across rating sources — doi.org.
  3. Health Resources and Services Administration, Maternal and Child Health Bureau, "Attention-Deficit/Hyperactivity Disorder (ADHD) prevalence and health care access, 2024," National Survey of Children's Health data brief — "A higher percentage of boys than girls had a current ADHD diagnosis (14.5% vs. 8.8%)" — hrsa.gov.
  4. Morrow RL, Garland EJ, Wright JM, Maclure M, Taylor S, Dormuth CR, "Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children," Canadian Medical Association Journal 184(7), 2012, 755–762 — 937,943 children; "Boys who were born in December were 30% more likely (relative risk [RR] 1.30, 95% confidence interval [CI] 1.23-1.37)… Girls born in December were 70% more likely (RR 1.70, 95% CI 1.53-1.88)… boys were 41% more likely (RR 1.41…) and girls 77% more likely (RR 1.77…) to be given a prescription" — pmc.ncbi.nlm.nih.gov.
  5. Wolraich ML, Hagan JF Jr, Allan C, et al., "Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents," Pediatrics 144(4), 2019, e20192528 — key action statements 2, 3 and 5c — pmc.ncbi.nlm.nih.gov.
  6. Danielson ML, Claussen AH, Bitsko RH, et al., "ADHD prevalence among U.S. children and adolescents in 2022," Journal of Clinical Child and Adolescent Psychology 53(3), 2024, 343–360 — "77.9% had at least one co-occurring disorder" — doi.org; Centers for Disease Control and Prevention, ADHD data and statistics — cdc.gov.
  7. Boen R, et al., "Attention and cognitive control in children with ADHD and comorbid anxiety disorder," Journal of Attention Disorders 30(8), 2026, 1036–1052 — "We did not find strong evidence for disorder-specific deficits in attention or cognitive control" — doi.org.
  8. Grizenko N, Qi Zhang DD, Polotskaia A, Joober R, "Efficacy of methylphenidate in ADHD children across the normal and the gifted intellectual spectrum," Journal of the Canadian Academy of Child and Adolescent Psychiatry 21(4), 2012, 282–288 — 502 children, double-blind placebo-controlled crossover; "No significant differences were found with regards to treatment response" — pmc.ncbi.nlm.nih.gov.
  9. Mowlem F, Agnew-Blais J, Taylor E, Asherson P, "Do different factors influence whether girls versus boys meet ADHD diagnostic criteria? Sex differences among children with high ADHD symptoms," Psychiatry Research 272, 2019, 765–773 — 283 children aged 7–12 with high ADHD symptoms; parents "under-rated diagnosed girls' hyperactive/impulsive symptoms compared to more objective interview assessment, with the opposite observed in boys" — doi.org.
  10. Cortese S, Adamo N, Del Giovane C, et al., "Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis," The Lancet Psychiatry 5(9), 2018, 727–738 — pmc.ncbi.nlm.nih.gov.

Paid for by participating therapists. Inclusion is computed from availability data — never purchased. No ads, no data sold.